Klivira
Request demo

Streamlining MatrixCare Prior Authorization for Gastroenterology

Klivira streamlines **MatrixCare prior authorization for gastroenterology**, automating the submission and tracking of high-volume GI biologics, procedures, and advanced imaging requests directly from your EMR.

Gastroenterology practices, especially those managing chronic conditions within long-term or post-acute care settings, face significant prior authorization burdens for biologics, complex procedures, and advanced diagnostics. Navigating these requirements efficiently within the MatrixCare EMR is critical for revenue cycle integrity and patient access to necessary GI treatments.

Optimizing Gastroenterology Prior Authorization within MatrixCare

MatrixCare, designed for long-term care, home health, and hospice, supports diverse patient populations, including those with chronic GI conditions requiring ongoing biologic therapies or specific diagnostic procedures. This environment necessitates robust prior authorization workflows to manage the high volume of requests for specialty GI drugs and interventions, ensuring continuity of care and financial stability.

High-Volume Prior Authorization Categories in Gastroenterology

  • IBD biologics (e.g., Humira, Stelara, Skyrizi, Entyvio) and specialty IBD drugs.
  • Advanced imaging for IBD assessment and other abdominal conditions (e.g., MRCP, MR enterography).
  • Endoscopic procedures with specific PA requirements, such as capsule endoscopy (CPT 91110) or ERCP.
  • Hepatitis C direct-acting antivirals (e.g., Epclusa, Mavyret), with pathways differing by treatment status.
  • Non-routine colonoscopy surveillance for high-risk patients or post-polypectomy.

Seamless Klivira Integration with MatrixCare APIs

Klivira integrates directly with MatrixCare APIs, enabling automated prior authorization submission and status updates. This integration allows Klivira to pull relevant clinical documentation from MatrixCare's patient records, such as medication histories, diagnostic results, and physician notes, which are crucial for meeting payer-specific GI medical necessity criteria.

Addressing Gastroenterology-Specific PA Workflow Constraints

GI prior authorization presents unique challenges, including the chronic re-authorization burden for IBD biologics and the variability in biosimilar substitution policies. Klivira's platform is designed to manage these complexities, ensuring accurate classification of treatment-naive vs. treatment-experienced patients and routing for medical versus pharmacy benefit where biologic administration modes may change.

Klivira's Intelligent Automation for Gastroenterology PA

  • ACG/AGA-guideline-aware step therapy logic for IBD biologic sequencing.
  • Automated treatment-status classification using EMR medication history.
  • Specialized workflow for Hepatitis C DAAs, including genotype and fibrosis stage documentation.
  • Periodic re-authorization workflow management for chronic IBD biologics.
  • Intelligent routing for medical vs. pharmacy benefit based on administration mode.

Mitigating Common Gastroenterology Prior Authorization Denials

Klivira helps reduce common GI prior authorization denials by ensuring comprehensive documentation. This includes verifying adherence to step therapy requirements for biologics, confirming disease severity metrics (e.g., Mayo score, CDAI), and validating pre-initiation screenings for IBD therapies, as well as accurate fibrosis stage documentation for Hepatitis C DAAs.

Frequently asked questions

How does Klivira handle the re-authorization process for chronic GI conditions like IBD within MatrixCare?

Klivira automates the periodic re-authorization workflow for chronic IBD biologics. It tracks re-authorization due dates, proactively gathers updated clinical documentation from MatrixCare, and submits the necessary information to payers, ensuring continuous patient access to critical therapies with minimal administrative burden.

Can Klivira differentiate between medical and pharmacy benefit for GI biologics ordered in MatrixCare?

Yes, Klivira's platform includes logic to route prior authorization requests based on whether a biologic is administered via infusion (medical benefit) or self-injection (pharmacy benefit). This is crucial for GI biologics, where the same agent might switch benefit sides depending on the administration mode or care setting, ensuring accurate submission.

What specific clinical documentation does Klivira retrieve from MatrixCare for GI prior authorizations?

Klivira leverages MatrixCare APIs to retrieve essential clinical documentation. This includes diagnosis confirmations, disease severity assessments (e.g., Mayo score, CDAI), prior conventional and biologic therapy trials, TB and hepatitis screening results, and relevant imaging or pathology reports needed for comprehensive GI PA submissions.

How does Klivira support compliance with payer step therapy requirements for IBD biologics?

Klivira incorporates ACG/AGA-guideline-aware step therapy logic. It analyzes the patient's medication history from MatrixCare to confirm adherence to payer-specific requirements, such as trial of conventional therapies or biosimilar substitution, flagging any potential non-compliance before submission to prevent denials.

Is Klivira compatible with MatrixCare's order entry workflows for GI procedures?

Klivira integrates with MatrixCare's underlying data structures, allowing it to initiate prior authorization workflows when specific GI procedures or specialty medications are ordered within MatrixCare. This ensures that PA is triggered early in the care pathway, minimizing delays and enhancing operational efficiency.

Related coverage

Other matrixcare prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo